Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Morris

Showing results (21-30 of 1,070) with videos related to

Pageof 107
Sort By:
Journal of Alzheimer'S Disease : JAD|July 12, 2005
Mild cognitive impairment (MCI) represents early-stage Alzheimer's diseaseJohn C Morris, Jeffrey Cummings
Archives of Neurology|November 10, 2010
Ascertainment bias in the clinical diagnosis of Alzheimer diseaseMartha Storandt, John C Morris
Thyroid : Official Journal of the American Thyroid Association|July 10, 2004
Gene therapy for thyroid cancer: current status and future prospectsChristine Spitzweg, John C Morris
Human Vaccines & Immunotherapeutics|June 3, 2017
Transforming growth factor-β: A therapeutic target for cancerSulsal Haque, John C Morris
Neurology|January 13, 2006
Demystifying lobar degenerations: tauopathies vs GehrigopathiesPaul G Ince, John C Morris
Advances in Immunology|May 30, 2006
Development of antibodies and chimeric molecules for cancer immunotherapyThomas A Waldmann, John C Morris
Neurology|June 28, 2006
Alzheimer neuropathology in nondemented aging: keeping mind over matterCarol F Lippa, John C Morris
Leukemia & Lymphoma|June 20, 2007
Therapeutic immunotoxins for lymphoid malignancies: the end of the beginningJohn C Morris, John E Janik
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2024
The role of the Alzheimer's Disease Neuroimaging Initiative in establishing the Dominantly Inherited Alzheimer NetworkJohn C Morris, Virginia D Buckles
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2006
Retroviral vectors encoding a reverse transcription-activated transgene efficiently limit expression of the gene to target cellsJohn Douglas Burke, John C Morris
Pageof 107

Showing results (21-30 of 1,070) with videos related to

Sort By:
Pageof 107
Journal of Alzheimer'S Disease : JAD|July 12, 2005
Mild cognitive impairment (MCI) represents early-stage Alzheimer's diseaseJohn C Morris, Jeffrey Cummings
Archives of Neurology|November 10, 2010
Ascertainment bias in the clinical diagnosis of Alzheimer diseaseMartha Storandt, John C Morris
Thyroid : Official Journal of the American Thyroid Association|July 10, 2004
Gene therapy for thyroid cancer: current status and future prospectsChristine Spitzweg, John C Morris
Human Vaccines & Immunotherapeutics|June 3, 2017
Transforming growth factor-β: A therapeutic target for cancerSulsal Haque, John C Morris
Neurology|January 13, 2006
Demystifying lobar degenerations: tauopathies vs GehrigopathiesPaul G Ince, John C Morris
Advances in Immunology|May 30, 2006
Development of antibodies and chimeric molecules for cancer immunotherapyThomas A Waldmann, John C Morris
Neurology|June 28, 2006
Alzheimer neuropathology in nondemented aging: keeping mind over matterCarol F Lippa, John C Morris
Leukemia & Lymphoma|June 20, 2007
Therapeutic immunotoxins for lymphoid malignancies: the end of the beginningJohn C Morris, John E Janik
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2024
The role of the Alzheimer's Disease Neuroimaging Initiative in establishing the Dominantly Inherited Alzheimer NetworkJohn C Morris, Virginia D Buckles
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2006
Retroviral vectors encoding a reverse transcription-activated transgene efficiently limit expression of the gene to target cellsJohn Douglas Burke, John C Morris
Pageof 107